in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Actavis to acquire Warner Chilcott in deal worth up to $8.5 billion
12:53 PM MDT | May 21, 2013 | Francinia Protti-Alvarez
Actavis (Parsippany, NJ) and Warner Chilcott (Dublin) have entered into a definitive agreement under which Actavis will acquire Warner Chilcott in a stock-for-stock transaction valued at approximately $5 billion, or $8.5 billion including net debt, the companies have announced. The deal represents a 43% premium compared with Warner Chilcott's volume-weighted average trading price of $14.00 for the 30-day trading period ended 9 May—the day before Warner Chilcott disclosed it was engaged in preliminary discussions with Actavis—and a 34% premium to the...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee